UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD

International journal of chronic obstructive pulmonary disease, 2017-01, Vol.12, p.3055-3064

2017

Volltextzugriff (PDF)

Bacterial regulation of macrophage bacterial recognition receptors in COPD are differentially modified by budesonide and fluticasone propionate

PloS one, 2019-01, Vol.14 (1), p.e0207675-e0207675

2019

Volltextzugriff (PDF)

Effects of fluticasone propionate and budesonide on the expression of immune defense genes in bronchial epithelial cells

Pulmonary pharmacology & therapeutics, 2018-06, Vol.50, p.47-56

2018

Volltextzugriff (PDF)

Low-Dose Budesonide/Formoterol Counteracts Airway Inflammation and Improves Lung Function in Chronic Obstructive Pulmonary Disease

American journal of respiratory and critical care medicine, 2019-03, Vol.199 (5), p.662-664

2019

Volltextzugriff (PDF)

Glucocorticoid-driven transcriptomes in human airway epithelial cells: commonalities, differences and functional insight from cell lines and primary cells

BMC medical genomics, 2019-01, Vol.12 (1), p.29-29, Article 29

2019

Volltextzugriff (PDF)

Cytokine-Induced Loss of Glucocorticoid Function: Effect of Kinase Inhibitors, Long-Acting β2-Adrenoceptor Agonist and Glucocorticoid Receptor Ligands

PloS one, 2015-01, Vol.10 (1), p.e0116773

2015

Volltextzugriff (PDF)

Advances in Asthma and COPD Treatment: Combination Therapy with Inhaled Corticosteroids and Long-Acting β2-Agonists

Current pharmaceutical design, 2006-09, Vol.12 (25), p.3261-3279

2006

Volltextzugriff (PDF)

An inhaled dose of budesonide induces genes involved in transcription and signaling in the human airways: enhancement of anti‐ and proinflammatory effector genes

Pharmacology research & perspectives, 2016-08, Vol.4 (4), p.e00243-n/a

2016

Volltextzugriff (PDF)

Budesonide and formoterol effects on rhinovirus replication and epithelial cell cytokine responses

Respiratory research, 2013-10, Vol.14 (1), p.98-98

2013

Volltextzugriff (PDF)

Protein tyrosine phosphatase PTP-RR regulates corticosteroid sensitivity

Respiratory research, 2016-03, Vol.17 (1), p.30, Article 30

2016

Volltextzugriff (PDF)

Modulation of transcriptional responses by poly(I:C) and human rhinovirus: Effect of long-acting β2-adrenoceptor agonists

European journal of pharmacology, 2013-05, Vol.708 (1-3), p.60-67

2013

Volltextzugriff (PDF)

Lung epithelial-C/EBPβ contributes to LPS-induced inflammation and its suppression by formoterol

Biochemical and biophysical research communications, 2012-06, Vol.423 (1), p.134-139

2012

Volltextzugriff (PDF)

Fluticasone propionate and increased risk of pneumonia in COPD: is it PAFR-dependent? Reply

International journal of chronic obstructive pulmonary disease, 2017, Vol.12, p.1427

2017

Volltextzugriff (PDF)

Tissue Accumulation Kinetics of Ciclesonide‐active Metabolite and Budesonide in Mice

Basic & clinical pharmacology & toxicology, 2013-06, Vol.112 (6), p.401-411

2013

Volltextzugriff (PDF)

Prolonged airway activity and improved selectivity of budesonide possibly due to esterification

American journal of respiratory and critical care medicine, 2000-10, Vol.162 (4), p.1455-1461

2000

Volltextzugriff (PDF)

Budesonide prevents cytokine-induced decrease of the relaxant responses to formoterol and terbutaline, but not to salmeterol, in mouse trachea

The Journal of pharmacology and experimental therapeutics, 2010-04, Vol.333 (1), p.273-280

2010

Volltextzugriff (PDF)

Anti-inflammatory activity of β2-agonists in primary lung epithelial cells is independent of glucocorticoid receptor

The European respiratory journal, 2007-11, Vol.30 (5), p.848-856

2007

Volltextzugriff (PDF)

Lung Fibroblast Proteoglycan Production Induced by Serum Is Inhibited by Budesonide and Formoterol

American journal of respiratory cell and molecular biology, 2006-01, Vol.34 (1), p.92-100

2006

Volltextzugriff (PDF)

The role of intracellular esterification in budesonide once-daily dosing and airway selectivity

Clinical therapeutics, 2003, Vol.25, p.C28-C41

2003

Volltextzugriff (PDF)

Increased corticosteroid sensitivity by a long acting β2 agonist formoterol via β2 adrenoceptor independent protein phosphatase 2A activation

Pulmonary pharmacology & therapeutics, 2012-06, Vol.25 (3), p.201-207

2012

Volltextzugriff (PDF)

Reversible fatty acid conjugation of budesonide. Novel mechanism for prolonged retention of topically applied steroid in airway tissue

Drug metabolism and disposition, 1998-07, Vol.26 (7), p.623

1998

Volltextzugriff (PDF)

The β2-subtype of adrenoceptors mediates inhibition of pro-fibrotic events in human lung fibroblasts

Naunyn-Schmiedeberg's archives of pharmacology, 2011-08, Vol.384 (2), p.133-145

2011

Volltextzugriff (PDF)

Effect of budesonide on fibroblast-mediated collagen gel contraction and degradation

Journal of inflammation research, 2013-01, Vol.6 (default), p.25-33

2013

Volltextzugriff (PDF)

Anti-inflammatory effects of budesonide in human lung fibroblasts are independent of histone deacetylase 2

Journal of inflammation research, 2013-08, Vol.6 (default), p.109-119

2013

Volltextzugriff (PDF)

Cytokine-induced loss of glucocorticoid function: effect of kinase inhibitors, long-acting β(2)-adrenoceptor [corrected] agonist and glucocorticoid receptor ligands

PloS one, 2015, Vol.10 (1), p.e0116773-e0116773

2015

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(83)

Publikationsform

Sprache

Englisch
(94)

Erscheinungsjahr

n.n

Thema

Science & Technology
(40)
Life Sciences & Biomedicine
(39)
Humans
(28)
Animals
(26)
Biological And Medical Sciences
(19)
Male
(19)
Budesonide
(18)
Asthma
(16)
Pharmacology & Pharmacy
(16)
Respiratory System
(16)
Budesonide - Pharmacology
(15)
Medical Sciences
(15)
Rats
(13)
Ethanolamines - Pharmacology
(12)
Formoterol Fumarate
(12)
Glucocorticoids
(12)
Medicin Och Hälsovetenskap
(12)
Asthma - Drug Therapy
(10)
Budesonide - Administration & Dosage
(10)
Bronchodilator Agents - Pharmacology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD

Bacterial regulation of macrophage bacterial recognition receptors in COPD are differentially modified by budesonide and fluticasone propionate

Effects of fluticasone propionate and budesonide on the expression of immune defense genes in bronchial epithelial cells

Low-Dose Budesonide/Formoterol Counteracts Airway Inflammation and Improves Lung Function in Chronic Obstructive Pulmonary Disease

Glucocorticoid-driven transcriptomes in human airway epithelial cells: commonalities, differences and functional insight from cell lines and primary cells

Cytokine-Induced Loss of Glucocorticoid Function: Effect of Kinase Inhibitors, Long-Acting β2-Adrenoceptor Agonist and Glucocorticoid Receptor Ligands

Advances in Asthma and COPD Treatment: Combination Therapy with Inhaled Corticosteroids and Long-Acting β2-Agonists

An inhaled dose of budesonide induces genes involved in transcription and signaling in the human airways: enhancement of anti‐ and proinflammatory effector genes

Budesonide and formoterol effects on rhinovirus replication and epithelial cell cytokine responses

Protein tyrosine phosphatase PTP-RR regulates corticosteroid sensitivity

Modulation of transcriptional responses by poly(I:C) and human rhinovirus: Effect of long-acting β2-adrenoceptor agonists

Lung epithelial-C/EBPβ contributes to LPS-induced inflammation and its suppression by formoterol

Fluticasone propionate and increased risk of pneumonia in COPD: is it PAFR-dependent? Reply

Tissue Accumulation Kinetics of Ciclesonide‐active Metabolite and Budesonide in Mice

Prolonged airway activity and improved selectivity of budesonide possibly due to esterification

Budesonide prevents cytokine-induced decrease of the relaxant responses to formoterol and terbutaline, but not to salmeterol, in mouse trachea

Anti-inflammatory activity of β2-agonists in primary lung epithelial cells is independent of glucocorticoid receptor

Lung Fibroblast Proteoglycan Production Induced by Serum Is Inhibited by Budesonide and Formoterol

The role of intracellular esterification in budesonide once-daily dosing and airway selectivity

Increased corticosteroid sensitivity by a long acting β2 agonist formoterol via β2 adrenoceptor independent protein phosphatase 2A activation

Reversible fatty acid conjugation of budesonide. Novel mechanism for prolonged retention of topically applied steroid in airway tissue

The β2-subtype of adrenoceptors mediates inhibition of pro-fibrotic events in human lung fibroblasts

Effect of budesonide on fibroblast-mediated collagen gel contraction and degradation

Anti-inflammatory effects of budesonide in human lung fibroblasts are independent of histone deacetylase 2

Cytokine-induced loss of glucocorticoid function: effect of kinase inhibitors, long-acting β(2)-adrenoceptor [corrected] agonist and glucocorticoid receptor ligands

Suchergebnisse filtern